Wai Chun Bio-Technology Issues Circular Covering Major and Discloseable Transactions, Advance to an Entity, and Upcoming EGM

Bulletin Express
03/31

Wai Chun Bio-Technology Limited released a bilingual circular on 31 March 2026 outlining four key matters: (1) Major Transactions, (2) Discloseable Transactions, (3) an Advance to an Entity, and (4) the Notice of an Extraordinary General Meeting (EGM).

The document is accessible on both the company’s website (www.0660.hk) and HKEX’s website (www.hkexnews.hk). Non-registered shareholders may request free printed copies through Union Registrars Limited, the Hong Kong branch share registrar, by written request or email.

Shareholders holding shares via banks, brokers, custodians, nominees, or HKSCC Nominees Limited can opt to receive future corporate communications electronically by providing a functional email address to their respective intermediaries. If no email address is supplied, electronic notification will not be sent.

Enquiries regarding the circular or the distribution arrangements can be directed to Union Registrars Limited at +852 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).

The circular’s release precedes the forthcoming EGM, details of which—including date, time, and venue—are provided within the published document.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10